{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T21:46:03Z","timestamp":1758404763719},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>IMPORTANCE:<\/jats:title>\n            <jats:p>This is the largest study describing the role of P450 epoxygenase metabolites in septic shock in humans and suggests a novel therapeutic target.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>Oxylipins are oxidative breakdown products of cell membrane fatty acids. Animal models have demonstrated that oxylipins generated by the P450 epoxygenase pathway may be implicated in septic shock pathology. However, these mediators are relatively unexplored in humans with septic shock. We aimed to determine if there were patterns of oxylipins that were associated with 28-day septic shock mortality and organ dysfunction.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design:<\/jats:title>\n            <jats:p>Retrospective analysis of samples collected during the Vasopressin versus Norepinephrine as Initial Therapy in Septic Shock trial.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Setting:<\/jats:title>\n            <jats:p>ICUs in the United Kingdom.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PARTICIPANTS:<\/jats:title>\n            <jats:p>Adults recruited within 6 hours of onset of septic shock.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MAIN OUTCOMES AND MEASURES:<\/jats:title>\n            <jats:p>Oxylipin profiling was performed on 404 serum samples from 152 patients using liquid chromatography-mass spectrometry.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Nonsurvivors were found to have higher levels of 14,15-dihydroxyeicosatrienoic acid (DHET) at baseline than survivors (<jats:italic toggle=\"yes\">p<\/jats:italic> = 0.02). Patients with 14,15-DHET levels above the lower limit of quantification of the assay were more likely to die than patients with levels below this limit (hazard ratio, 2.3; 95% CI, 1.2\u20134.5). Patients with measurable 14,15-DHET had higher levels of organ dysfunction and fewer renal failure-free days than those in whom it was unmeasurable. Considering samples collected over the first week of intensive care stay, measurable levels of DHET species were associated with higher daily Sequential Organ Failure Assessment scores that appeared to be accounted for predominantly by the liver component. Measurable 14,15-DHET showed positive correlation with bilirubin (<jats:italic toggle=\"yes\">r<\/jats:italic>\n                                 <jats:sub>s<\/jats:sub> = 0.38; <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.001) and lactate (<jats:italic toggle=\"yes\">r<\/jats:italic>\n                                 <jats:sub>s<\/jats:sub> = 0.27; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS AND RELEVANCE:<\/jats:title>\n            <jats:p>The P450 epoxygenase-derived DHET species of oxylipins were associated with organ, particularly liver, dysfunction in septic shock and 14,15-DHET was associated with septic shock mortality. These results support further investigation into the role of the P450 epoxygenase-derived oxylipins in sepsis and suggest that this pathway may offer a novel therapeutic strategy in septic shock.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cce.0000000000000622","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T19:05:43Z","timestamp":1642791943000},"page":"e0622","update-policy":"http:\/\/dx.doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["A Novel Role for Cytochrome P450 Epoxygenase Metabolites in Septic Shock"],"prefix":"10.1097","volume":"4","author":[{"given":"Timothy N.","family":"Jones","sequence":"first","affiliation":[{"name":"Division of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila","family":"Janani","sequence":"additional","affiliation":[{"name":"Imperial Clinical Trials Unit, School of Public Health, Faculty of Medicine, Imperial College London, London, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony C.","family":"Gordon","sequence":"additional","affiliation":[{"name":"Division of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom."},{"name":"Department of Health and Social Care, Centre for Antimicrobial Optimization at Imperial College, London, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farah","family":"Al-Beidh","sequence":"additional","affiliation":[{"name":"Division of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David B.","family":"Antcliffe","sequence":"additional","affiliation":[{"name":"Division of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom."},{"name":"Department of Health and Social Care, Centre for Antimicrobial Optimization at Imperial College, London, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,1,21]]},"reference":[{"key":"R1-20240807","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1208623","article-title":"Severe sepsis and septic shock.","volume":"369","author":"Angus","year":"2013","journal-title":"N Engl J Med"},{"key":"R2-20240807","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.plaphy.2008.12.011","article-title":"Oxylipins: Structurally diverse metabolites from fatty acid oxidation.","volume":"47","author":"Mosblech","year":"2009","journal-title":"Plant Physiol Biochem"},{"key":"R3-20240807","doi-asserted-by":"crossref","first-page":"696897","DOI":"10.1155\/2012\/696897","article-title":"Cyclooxygenase inhibition in sepsis: Is there life after death?","volume":"2012","author":"Aronoff","year":"2012","journal-title":"Mediators Inflamm"},{"key":"R4-20240807","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1056\/NEJM199703273361303","article-title":"The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group.","volume":"336","author":"Bernard","year":"1997","journal-title":"N Engl J Med"},{"key":"R5-20240807","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0022-2275(20)32049-6","article-title":"Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase.","volume":"41","author":"Capdevila","year":"2000","journal-title":"J Lipid Res"},{"key":"R6-20240807","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/FJC.0b013e318273b007","article-title":"Epoxyeicosatrienoic acid pathway in human health and diseases.","volume":"61","author":"Bellien","year":"2013","journal-title":"J Cardiovasc Pharmacol"},{"key":"R7-20240807","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1161\/01.CIR.0000047278.28407.C2","article-title":"Endothelium-derived hyperpolarizing factor in human internal mammary artery is 11,12-epoxyeicosatrienoic acid and causes relaxation by activating smooth muscle BK(Ca) channels.","volume":"107","author":"Archer","year":"2003","journal-title":"Circulation"},{"key":"R8-20240807","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1161\/ATVBAHA.107.152074","article-title":"Epoxyeicosatrienoic acids regulate Trp channel dependent Ca2+ signaling and hyperpolarization in endothelial cells.","volume":"27","author":"Fleming","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R9-20240807","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1161\/01.RES.0000155332.17783.26","article-title":"Epoxyeicosatrienoic acids are released to mediate shear stress-dependent hyperpolarization of arteriolar smooth muscle.","volume":"96","author":"Huang","year":"2005","journal-title":"Circ Res"},{"key":"R10-20240807","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1096\/fj.10-160119","article-title":"Endothelial expression of human cytochrome P450 epoxygenases lowers blood pressure and attenuates hypertension-induced renal injury in mice.","volume":"24","author":"Lee","year":"2010","journal-title":"FASEB J"},{"key":"R11-20240807","doi-asserted-by":"crossref","first-page":"H2470","DOI":"10.1152\/ajpheart.2001.280.6.H2470","article-title":"Characterization of endothelium-derived hyperpolarizing factor in the human forearm microcirculation.","volume":"280","author":"Halcox","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R12-20240807","doi-asserted-by":"crossref","first-page":"H1347","DOI":"10.1152\/ajpheart.01079.2005","article-title":"Evidence for a basal release of a cytochrome-related endothelium-derived hyperpolarizing factor in the radial artery in humans.","volume":"290","author":"Bellien","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R13-20240807","doi-asserted-by":"crossref","first-page":"15054","DOI":"10.1038\/cddiscovery.2015.54","article-title":"CYP-epoxygenase metabolites of docosahexaenoic acid protect HL-1 cardiac cells against LPS-induced cytotoxicity through SIRT1.","volume":"1","author":"Samokhvalov","year":"2015","journal-title":"Cell Death Discov"},{"key":"R14-20240807","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/SHK.0000000000001408","article-title":"sEH Inhibitor TPPU ameliorates cecal ligation and puncture-induced sepsis by regulating macrophage functions.","volume":"53","author":"Chen","year":"2020","journal-title":"Shock"},{"key":"R15-20240807","doi-asserted-by":"crossref","first-page":"50958","DOI":"10.18632\/oncotarget.17331","article-title":"EETs reduces LPS-induced hyperpermeability by targeting GRP78 mediated Src activation and subsequent Rho\/ROCK signaling pathway.","volume":"8","author":"Dong","year":"2017","journal-title":"Oncotarget"},{"key":"R16-20240807","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/CCM.0000000000002014","article-title":"Human sepsis eicosanoid and proresolving lipid mediator temporal profiles: Correlations with survival and clinical outcomes.","volume":"45","author":"Dalli","year":"2017","journal-title":"Crit Care Med"},{"key":"R17-20240807","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/ams2.443","article-title":"A case series of the dynamics of lipid mediators in patients with sepsis.","volume":"6","author":"Hamaguchi","year":"2019","journal-title":"Acute Med Surg"},{"key":"R18-20240807","doi-asserted-by":"crossref","first-page":"14736","DOI":"10.1038\/s41598-018-32938-6","article-title":"Profiling inflammatory markers in patients with pneumonia on intensive care.","volume":"8","author":"Antcliffe","year":"2018","journal-title":"Sci Rep"},{"key":"R19-20240807","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/jama.2016.10485","article-title":"Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: The VANISH Randomized Clinical Trial.","volume":"316","author":"Gordon","year":"2016","journal-title":"JAMA"},{"key":"R20-20240807","doi-asserted-by":"crossref","first-page":"11721","DOI":"10.1021\/acs.analchem.5b02794","article-title":"Development and validation of a high-throughput ultrahigh-performance liquid chromatography-mass spectrometry approach for screening of oxylipins and their precursors.","volume":"87","author":"Wolfer","year":"2015","journal-title":"Anal Chem"},{"key":"R21-20240807","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12967-017-1171-2","article-title":"Longitudinal analysis of serum oxylipin profile as a novel descriptor of the inflammatory response to surgery.","volume":"15","author":"Wolfer","year":"2017","journal-title":"J Transl Med"},{"key":"R22-20240807","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jcrc.2020.11.002","article-title":"Vasopressor dose equivalence: A scoping review and suggested formula.","volume":"61","author":"Goradia","year":"2021","journal-title":"J Crit Care"},{"key":"R25-20240807","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1161\/01.RES.83.9.932","article-title":"Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation.","volume":"83","author":"Oltman","year":"1998","journal-title":"Circ Res"},{"key":"R26-20240807","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1469-7793.2001.t01-1-00651.x","article-title":"Dihydroxyeicosatrienoic acids are potent activators of Ca(2+)-activated K(+) channels in isolated rat coronary arterial myocytes.","volume":"534","author":"Lu","year":"2001","journal-title":"J Physiol"},{"key":"R27-20240807","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11306-018-1326-z","article-title":"Omega-6-derived oxylipin changes in serum of patients with hepatitis B virus-related liver diseases.","volume":"14","author":"Lu","year":"2018","journal-title":"Metabolomics"},{"key":"R28-20240807","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1007\/s12035-020-01925-2","article-title":"Prolonged soluble epoxide hydrolase reactivity in brain endothelial cells is associated with long cognitive deficits in sepsis.","volume":"57","author":"Wang","year":"2020","journal-title":"Mol Neurobiol"},{"key":"R29-20240807","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.gene.2013.05.008","article-title":"Soluble epoxide hydrolase: Gene structure, expression and deletion.","volume":"526","author":"Harris","year":"2013","journal-title":"Gene"},{"key":"R30-20240807","first-page":"203","article-title":"The role of hepatic cytochrome P-450 in sepsis.","volume":"2","author":"Jacob","year":"2009","journal-title":"Int J Clin Exp Med"},{"key":"R31-20240807","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.3389\/fphar.2018.01572","article-title":"Deficiency of soluble epoxide hydrolase protects cardiac function impaired by LPS-induced acute inflammation.","volume":"9","author":"Samokhvalov","year":"2018","journal-title":"Front Pharmacol"},{"key":"R32-20240807","first-page":"E124","article-title":"Soluble epoxide hydrolase inhibition in liver diseases: A review of current research and knowledge gaps.","volume":"9","author":"Warner","year":"2020","journal-title":"Biology (Basel)"},{"key":"R33-20240807","first-page":"669","article-title":"Role of cytokines as a double-edged sword in sepsis.","volume":"27","author":"Chaudhry","year":"2013","journal-title":"In Vivo"},{"key":"R34-20240807","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10753-016-0448-6","article-title":"Soluble epoxide hydrolase inhibitor suppresses the expression of triggering receptor expressed on myeloid cells-1 by inhibiting NF-kB activation in murine macrophage.","volume":"40","author":"Dong","year":"2017","journal-title":"Inflammation"},{"key":"R35-20240807","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1002\/jcp.24939","article-title":"Epoxyeicosatrienoic acids regulate macrophage polarization and prevent LPS-induced cardiac dysfunction.","volume":"230","author":"Dai","year":"2015","journal-title":"J Cell Physiol"}],"container-title":["Critical Care Explorations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000000622","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T14:29:57Z","timestamp":1723040997000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000000622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/cce.0000000000000622","relation":{},"ISSN":["2639-8028"],"issn-type":[{"type":"electronic","value":"2639-8028"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}